08:04 AM EST, 02/14/2025 (MT Newswires) -- US stock futures were trending modestly lower in Friday's premarket session as investors await retail sales and industrial production figures later in the morning.

Dow Jones Industrial Average futures were down 0.27%, S&P 500 futures were off 0.15%, and Nasdaq futures were declining 0.16%.

Oil prices were moving higher, with front-month global benchmarks Brent crude and West Texas Intermediate crude rising 0.89% and 0.73% respectively.

Retail sales for January are expected to decline 0.2% after gaining 0.4% the previous month, according to Bloomberg. Industrial production is expected to increase 0.3% in January, following a 0.9% gain in December.

In equities, shares of WeRide ( WRD ) soared 95% in Friday's premarket session, adding to a 3.7% gain on Thursday. Virpax Pharmaceuticals' ( VRPX ) shares advanced 76% after saying late Thursday that it completed the full study that followed the initial Probudur pilot study performed by the US Army Institute of Surgical Research. Moleculin Biotech's ( MBRX ) stock surged 65%, adding to a huge 202% gain in the previous session.

On the losing side, shares of Bellevue Life Sciences Acquisition ( BLAC ) plunged 41%, more than wiping out a 13% gain on Thursday. Jerash ( JRSH ) shares tumbled 37% after a 2.6% gain in the previous session, and shares of Mynaric ( MYNA ) shed 36%, piling on to a 32% loss on Thursday after saying it received a Nasdaq delisting notice.